Valuation: Star Scientific, Inc.

Market Cap 2L 1L 1L 1L 2L 1.46Cr 2L 14.8L 6L 71.8L 6L 6L 2.47Cr P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 2Cr 1.75Cr 1.61Cr 1.5Cr 2.84Cr 190.53Cr 2.89Cr 19Cr 7.5Cr 94Cr 7.51Cr 7.35Cr 322.73Cr EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.86%+0.48%+55.50%+160.66% 1,08200Cr
+3.57%+3.29%+68.60%+61.56% 63TCr
+3.99%+3.05%+37.93%+89.70% 46TCr
-1.41%+1.37%+31.00%+23.05% 34TCr
-0.98%+0.34%+40.40%+38.90% 30TCr
-0.42%+0.97%+30.54%+45.34% 29TCr
-0.34%+3.54%-26.10%-39.74% 22TCr
+3.55%+4.41%+25.45%+65.64% 20TCr
+4.21%+2.65%+17.47%+69.95% 16TCr
Average +0.98%+4.45%+31.20%+57.23% 41.03TCr
Weighted average by Cap. +0.75%+5.43%+41.89%+82.00%

Financials

2014 2015
Net sales - -
Net income -3.85Cr -3.37Cr -3.09Cr -2.88Cr -5.47Cr -366.74Cr -5.55Cr -37Cr -14Cr -180.27Cr -14Cr -14Cr -621.2Cr -68.45L -59.84L -54.99L -51.26L -97.22L -65Cr -98.7L -6.6Cr -2.57Cr -32Cr -2.57Cr -2.51Cr -110.4Cr
Net Debt -45T -39.34T -36.15T -33.7T -63.92T -42.85L -64.89T -4L -2L -21.06L -2L -2L -72.58L 1.99Cr 1.74Cr 1.6Cr 1.49Cr 2.82Cr 189.07Cr 2.86Cr 19Cr 7.45Cr 93Cr 7.45Cr 7.29Cr 320.25Cr
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-